Capital Impact Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,075
Closed -$611K 146
2023
Q2
$611K Sell
9,075
-9,074
-50% -$553K 0.67% 61
2023
Q1
$934K Buy
18,149
+476
+3% +$23.1K 1.15% 8
2022
Q4
$813K Hold
17,673
0.79% 26
2022
Q3
$798K Buy
17,673
+1,599
+10% +$79.9K 0.79% 25
2022
Q2
$732K Sell
16,074
-7,746
-33% -$346K 0.68% 38
2022
Q1
$1.11M Sell
23,820
-20,566
-46% -$920K 0.81% 24
2021
Q4
$2.23M Hold
44,386
1.54% 19
2021
Q3
$2.36M Hold
44,386
0.93% 43
2021
Q2
$2.71M Sell
44,386
-20,787
-32% -$1.1M 0.87% 45
2021
Q1
$3.18M Hold
65,173
1.11% 37
2020
Q4
$2.64M Hold
65,173
0.65% 66
2020
Q3
$2.12M Hold
65,173
0.63% 76
2020
Q2
$1.72M Hold
65,173
0.57% 83
2020
Q1
$1.62M Buy
65,173
+3,118
+5% +$96.3K 0.68% 69
2019
Q4
$2.23M Buy
62,055
+3,297
+6% +$114K 0.79% 56
2019
Q3
$1.99M Sell
58,758
-9,227
-14% -$295K 0.76% 61
2019
Q2
$1.89M Buy
67,985
+5,780
+9% +$161K 0.69% 66
2019
Q1
$1.46M Hold
62,205
0.65% 87
2018
Q4
$1.46M Buy
62,205
+10,663
+21% +$291K 0.63% 90
2018
Q3
$1.93M Hold
51,542
0.66% 71
2018
Q2
$1.74M Buy
51,542
+7,478
+17% +$266K 0.64% 86
2018
Q1
$1.6M Buy
+44,064
New +$1.53M 0.66% 69

Other funds holding LMAT

Capital Impact Advisors's LMAT Position: Q3 2023 in Review

Capital Impact Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2023, closing a stake of 9,075 shares — an estimated $611K sold.

Capital Impact Advisors first reported a position in LMAT in Q1 2018 and held it in 22 quarters. The position peaked at $3.18M in Q1 2021. 220 funds tracked by Wall St. Rank hold LMAT as of Q3 2023.

  • Capital Impact Advisors reported no remaining LeMaitre Vascular position as of Q3 2023 after selling out during the quarter.
  • Capital Impact Advisors sold 9,075 LeMaitre Vascular shares in Q3 2023, an estimated $611K.
  • Capital Impact Advisors first reported a position in LeMaitre Vascular in Q1 2018 and held it in 22 quarters.
  • Capital Impact Advisors's LeMaitre Vascular position peaked at $3.18M in Q1 2021.
  • 220 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2023.

Based on Capital Impact Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.